University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 25 of 29
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
NCT00974259
Transoral Robotic Surgery (TORS) for Sleep Apnea
NCT01187160
Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study
NCT01153464
The Effect of Time-Slot Scheduling on Flu Vaccination Rates
NCT01206686
A Patient Advocate and Literacy-Based Treatment of Asthma
NCT01128348
Increasing Primary Care Physician Colorectal Cancer Screening Rates
NCT00955344
Surgery Or Lifestyle Intervention for Type 2 Diabetes (SOLID)
NCT01040468
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
NCT00966446
Lifestyle Modification and Blood Pressure Study
NCT00964847
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine
NCT00956943
Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip
NCT00957827
Prevention of Relapse & Recurrence of Bipolar Depression
NCT00961961
Improving Diabetes Control Through Peer Counseling and Incentives
NCT01125956
VIVITROL as a Treatment for Cocaine and Alcohol Dependence
NCT00777062
Trial of Topical Cidofovir for the Prevention of Hair Growth
NCT00948506
Predictors of Anticoagulation Control on Warfarin Therapy
NCT00905177
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
NCT01047527
Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
NCT00929669
Add On Treatment for Cognitive Deficits in Schizophrenia
NCT01346163
CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia
NCT01013441
The Effects of Treating Obese and Lean Patients With Sleep Apnea
NCT01578031
Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH)
NCT00913081
Healthy Brains & Behavior: Understanding and Treating Youth Aggression
NCT00842439
Dietary Intake and Eating Behaviors in Adolescents Who Undergo Bariatric Surgery
NCT00721838
Treatment of Smoking Among Individuals With PTSD
NCT00937235
Integrating Depression Services Into DM Management
NCT01098253
Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
NCT00842634
Umbilical Cord Blood Transplant for Hematological Malignancies
NCT00891592
Measuring Smoking Behaviors While Using Varenicline
NCT00948155
Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)
NCT00814099
GLP 1 for Intraoperative Glycemic Control
NCT00882492
Eating Behaviors Among Weight-Discordant Siblings
NCT01598389
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
NCT00775684
Adaptive Treatment for Alcohol and Cocaine Dependence
NCT01032135
Examining Behavior Therapy for Trichotillomania in Children and Adolescents
NCT00917098
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
NCT00780325
PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
NCT00775424
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
NCT00766038
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
NCT00728819
West Philadelphia Consortium Randomized Control Trial
NCT01299883
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
NCT00683670
Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth
NCT01610219
Oocyte Cryopreservation Study (Egg Banking)
NCT02396095
Pilot Study of Tolcapone in Smokers
NCT01202955
µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis
NCT01153425
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
NCT00781898
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
NCT00728910
Varenicline (Chantix™) for the Treatment of Alcohol Dependence
NCT00705523
Testing Strategies for Weight Loss, II
NCT00739492
The Biomarker Study
NCT01148654
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.